Berkshire Hathaway's cash and short-term Treasuries stood at approximately $360 billion at the end of the second quarter, a $9 billion decrease from the $369 billion inherited by CEO Greg Abel at the end of 2025. The company was a net buyer of roughly $12 billion in equity securities during the first half of 2026. Additionally, Berkshire made three deals, including the $9.7 billion OxyChem acquisition, the $8.5 billion Taylor Morrison acquisition, and a $10 billion private placement with Alphabet.